Serum and urine interleukin ‐17A levels as biomarkers of disease activity in systemic lupus erythematosus

ConclusionDespite positive correlations between serum and urine IL ‐17A with SLE disease activity, both were neither sensitive nor specific as biomarkers to predict active disease. Hence, IL‐17 measurement has no role in SLE disease activity assessments and future studies are needed to search for other reliable activity biomarkers.
Source: International Journal of Rheumatic Diseases - Category: Rheumatology Authors: Tags: ORIGINAL ARTICLE Source Type: research